CXCR3 and myeloid sarcoma: Here, we demonstrated that not only expression of CXCR3 on CD3+ lymphocytes, but also their ability to migrate under the chemotactic stimulus of CXCL10, which has a relevant role in the pathophysiology of MS [52], is inhibited by MSC.